Table 3. Factors Associated With the Development of Recurrent CBDS After Endoscopic Treatment for CBDS Around the Perioperative Period in Cholecystectomy.
| Univariate OR (95% CI) | P value | Multivariate OR (95% CI) | P value | |
|---|---|---|---|---|
| Gender, female | 1.143 (0.314 - 4.160) | 0.839 | ||
| Age, years | 0.961 (0.903 - 1.023) | 0.211 | ||
| Maximum diameter of GS, mm | 1.083 (0.949 - 1.236) | 0.238 | ||
| Patients with multiple GS (≥ 5) | 1.143 (0.314 - 4.160) | 0.839 | ||
| Cholangitis on admission | 1.429 (0.372 - 5.487) | 0.603 | ||
| Maximum diameter of CBDS, mm | 0.997 (0.816 - 1.218) | 0.975 | ||
| Patients with multiple CBDS (≥ 5) | 0.250 (0.039 - 1.582) | 0.141 | 0.218 (0.030 - 1.586) | 0.132 |
| Minimal diameter of cystic duct, mm | 0.664 (0.459 - 0.962) | 0.03* | 0.611 (0.398 - 0.939) | 0.025* |
| Residual CBDS at first ERC | 0.999 | |||
| Days between first ERC and operation | 0.984 (0.962 - 1.008) | 0.185 | 0.974 (0.946 - 1.003) | 0.084 |
| Laparoscopic cholecystectomy | 0.999 | |||
| Operation time, min | 1.000 (0.984 - 1.017) | 0.958 | ||
| Days between operation and second ERC | 0.997 (0.959 - 1.036) | 0.862 |
Results are presented as a number (n) or mean n (%) for qualitative data or as median (range) for quantitative data. *P < 0.05. GS: gallstones; CBDS: common bile duct stones; ERC: endoscopic retrograde cholangiography; CI: confidence interval.